AI + EXCLUSIVE DATA

AI analyzes funding data you can't access anywhere else

Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.

10-25 personalized leads daily • 92% average intent score • Smart feed technology

Start with:

✓Flexible Plans • $39/mo or $29/mo annual

✓AI + real-time funding intelligence

✓Never see duplicates in your feed

INDUSTRY FIRST

Andera Partners Backs $60 Million Series C For Hypertension Medtech Sonivie

Jan 15, 2023•over 2 years ago

Amount Raised

$60 Million

Round Type

series c

St. PaulMedical DeviceMedical

Investors

Tech WaldOmega FundsSupernova InvestAndera Partners

Description

SoniVie, an Italy and Israel-run med tech seeking to treat hypertension through the use of ultrasound, has closed a $60 million series C round to make headway toward its clinical and regulatory pipeline.

Company Information

Company

SoniVie

Location

St. Paul, Minnesota, United States

About

Founded in 2014 on the achievements of the Therapeutic Intra-Vascular UltraSound-based technology (TIVUS) developed by Cardiosonic for Renal Artery Denervation, Sonivie further developed the technology for Pulmonary Hypertension. TIVUS has been performing clinical trials in both PAH and RDN and has been awarded three Breakthrough Device Designation from the US FDA to treat PAH patients and Uncontrolled and Resistant Hypertension patients, and has obtained a Premarket Application for FDA approval for PAH.

FundzWatch™ Score

Medium Activity

Related People

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech